Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Results of Onconase trial in malignant mesothelioma reported

March 31, 1999

ACS highlights: Dainippon selects potent antitumor compound for development

March 30, 1999

New antileukemia agents synthesized at Hughes Institute

March 30, 1999

New differentiation-inducing vitamin D compounds from Japanese lab

March 30, 1999

U. of California reports new purine cyclin-dependent kinase inhibitors

March 30, 1999

NCI initiates pilot trial of thalidomide as adjunct in cancer therapy

March 30, 1999

Bioniche technology offers synergistic benefits in cancer therapy

March 29, 1999

Sugen's new protein tyrosine kinase inhibitors

March 26, 1999

Searle characterizes new vitronectin antagonist with antitumor activity at ACS meeting

March 25, 1999

MethylGene initiates phase I clinical trials of MG-98 for solid tumors

March 25, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
Deerfield-backed Boulevard, Metis pen $1.6B trispecific TCE deal
BioWorld
A U.S. biotechnology company founded by Deerfield Management Company L.P. licensed exclusive rights to Metis Techbio Co. Ltd.’s preclinical trispecific T-cell...